Lotus Lake Ventures

Lotus Lake Ventures Management (Beijing) Co., Ltd. is a venture capital firm based in Beijing, China, with an additional office in Hangzhou. Established in 2001, it is a subsidiary of Tus-Holdings Co., Ltd. The firm focuses on investing in startup and early-stage enterprises, particularly in sectors such as information technology, life sciences, clean technology, advanced manufacturing, new materials, and creative industries including media and telecommunications. Lotus Lake Ventures aims to support high-tech companies and innovation-driven enterprises that demonstrate significant core competitiveness during their initial and growth phases.

Zhou Han

Managing Director

Dong Hou

Partner

Tao Jiang

Investment Director

Guo Kai

Managing Director

Zhao Lei Ph.D

Managing Director

Guangchao Li

Managing Director

Huiqin Liu

Managing Director

Nie Feilong Ph.D

Vice President

Jun Xue

Co-Founding Partner and Managing Director

Lei Yang

Principal

Ke Yu

Investment Director

Shanliang Zhang

Managing Director

Fuqiang Zhao

Investment Director

Jiman Zhu Ph.D

Principal

35 past transactions

Hongyun Biology

Series B in 2023
Hongyun Biology is a biotechnology company dedicated to developing new drugs through structural pharmacology. The firm addresses unmet medical needs, particularly those arising from conditions such as cancer drug resistance and other untreatable diseases. By focusing on therapeutic innovation, Hongyun Biology aims to provide patients with access to advanced treatments that improve health outcomes.

China Immunotech

Series B in 2022
China Immunotech is a research and development company specializing in innovative small molecule drugs and cellular immunotherapy. Founded in March 2018 by renowned immunologists, the company focuses on developing immune cell therapy technologies, including CAR-T and TCR-T cell therapies, which are supported by independent intellectual property rights. China Immunotech aims to advance the commercialization of these therapies to treat various diseases, particularly targeting hematological tumors. Its unique technology platforms, STAR-T and TCR-T, are designed to provide effective treatment options for patients while also addressing the challenge of tumor recurrence.

NeuralGalaxy

Series A in 2021
Neural Galaxy is a brain science company that originated at Harvard Medical School and the Massachusetts Institute of Technology. The mission of Younao Galaxy is to help solve brain diseases and achieve greater intelligence. Focusing on global vision, based on breakthrough brain science research results, using new software and hardware technologies, Younao Galaxy helps humans to deeply understand our brains, understand high-level intelligence, and solve the enormous challenges facing human society.

Slichem

Series A in 2021
Slichem develops liquid crystal materials and fine chemicals. They manufacture display materials. Their products include liquid crystal materials for display and OLED materials.

Chinagene Tech

Seed Round in 2021
Beijing Zhongyin Technology Co., Ltd. is a professional enterprise engaged in the research and development of clinical genetic diagnosis, prevention and gene therapy for hereditary eye diseases. The company's clinical genetic diagnosis platform for hereditary eye diseases can provide fast, accurate, reliable and professional clinical genetic diagnosis services for hereditary ophthalmology patients.

Insight Lifetech

Series B in 2020
Insight Lifetech Co., Ltd. is a Chinese company focused on the development and manufacturing of medical equipment for heart intervention. The firm specializes in creating high-quality devices designed to enhance the diagnosis and therapy of cardiovascular diseases. By utilizing innovative technologies, Insight Lifetech aims to provide reliable precision in medical treatments, ultimately enabling healthcare professionals to save and improve patients' lives.

OptoMedic

Series C in 2020
Guangzhou OptoMedic Co., Ltd. engages in research, development, and manufacture of optical medical device and systems. It offers intraoperative endoscopic fluorescence navigation system for general surgery departments. The company was founded in 2013 and is based in Foshan, China.

Sensylink

Series B in 2019
Sensylink Microelectronics Co., Ltd. specializes in the design, development, manufacturing, and marketing of environmental sensor integrated circuits (ICs), including those for temperature, humidity, and gas detection. The company focuses on creating compact and energy-efficient sensors that enable enterprises to enhance their measurement devices. Sensylink's products are characterized by high precision, miniature size, low power consumption, and cost-effectiveness, achieved through the integration of innovative sensor technology with advanced IC design and processing techniques. Based in China, Sensylink aims to provide customers worldwide with reliable and economical environmental sensor components and services.

Lidakang Technology

Series A in 2019
Beijing Lidakang Technology Co., Ltd. specializes in the development and manufacture of surgical implants, focusing on artificial joints. Established in 1998 and based in Beijing, China, the company provides a range of products including a microporous titanium alloy hip joint system, a stable knee joint system with enhanced flexibility, and a joint system designed for bone tumors. Lidakang Technology is committed to delivering high-quality surgical joint implants to healthcare professionals, facilitating improved outcomes in joint replacement surgeries.

Hanyu Medical

Series B in 2018
Shanghai Hanyu Medical Technology Co., Ltd. specializes in the research and development of medical devices aimed at treating heart valve diseases. Established in 2016 and headquartered in Shanghai, with an additional office in Beijing, the company is recognized as one of the pioneering domestic firms in the development, production, and sale of transcatheter mitral valve repair devices. Hanyu Medical's flagship product, ValveClamp, is designed for minimally invasive interventions to address mitral valve regurgitation, enabling surgeons to close heart valves efficiently during procedures.

Kanova

Series A in 2018
Kanova is a biopharmaceutical firm.

Kiwi Green Technologies

Series A in 2018
Kiwi Green Technologies is a developer of recycling and environmental energy technologies. The company focuses on recycling waste to generate new energy, contributing to the production of green and renewable energy. By providing innovative solutions for both government and corporate entities, Kiwi Green Technologies aims to significantly reduce the costs associated with treating environmental pollutants.

IntEngine

Series A in 2018
IntEngine is a Beijing-based robotics company specializing in the development of software algorithms and chip hardware technology aimed at enhancing efficiency in daily life. The company focuses on deep learning and machine learning algorithms, providing tailored neural networks and terminal equipment. Additionally, IntEngine assists in upgrading security monitoring systems, offering advanced digitalization solutions for industrial users. Through its innovative approach, IntEngine aims to improve operational efficiency and security in various sectors.

Sinogene

Series A in 2018
Beijing Sinogene Biotechnology Co., Ltd. is engaged in commercial pet cloning and gene editing technology services. The firm was founded in 2012 and is headquartered in Beijing, China.

Suzhou Ribo Life Science

Series B in 2017
Suzhou Ribo Life Science is a developer of RNA interference ( RNAi ) technology designed to treat liver diseases. The company's RNA interference ( RNAi ) technology is used to develop nucleic acid therapeutic drugs and related products, enabling healthcare providers to deliver more effective pharmaceuticals to patients.

ZIYAN UAV

Series A in 2016
Developer of intelligent unmanned helicopters and drones to be applied in a variety of scenarios. The company's unmanned helicopters are applied in small and medium-sized logistics, rescue operations, border patrols and etc., with characteristics of high speed, high maximum takeoff weight, and high efficacy.

Laviana Pharma

Series A in 2014
Laviana Pharma Co., Ltd. founded in 2005 is a high-tech enterprise. It specializes in providing process and manufacture outsourcing services (CDMO) for the pharmaceutical industry. The main scope of services covers all chemistry-related aspects of process development and transformation for the innovative drug substances and products from laboratory scale to commercialized scale, including process research, process development, process optimization, pilot production and large-scale production of intermediates, API starting materials and API (active pharmaceutical ingredient) for pre-clinical, clinical trial materials and commercialized products. It also provides CMC services for IND and NDA submission of innovative developmental drug. It has three wholly-owned subsidiary, namely, Beijing laviana Pharmatech Co., Ltd., Laviana (Tianjin) Pharmatech Development Co., Ltd., and Laviana Corporation incorporated in United States.

SolarVista Media

Series D in 2013
SolarVista Media Co., Ltd is a Chinese company specializing in outdoor advertising through innovative billboards. The company offers DCP billboards that utilize natural light to display digital images, allowing for seamless electronic updates without generating plastic waste during campaign transitions. This environmentally friendly approach positions SolarVista Media as a forward-thinking player in the advertising industry, focusing on sustainable practices while delivering effective advertising solutions.

Palmap

Series B in 2013
Palmap, Inc. is an indoor map service provider based in Shanghai, China, specializing in indoor localization and navigation solutions. Founded in 2010, Palmap has established itself as a leader in the field, boasting the largest indoor map database in China, which includes 20,000 indoor maps and over 3.5 million points of interest across 350 cities. The company offers comprehensive services to various sectors, including commercial complexes, tourist destinations, hospitals, and transportation centers. Palmap's advanced map engine supports multiple formats, including 2D, 2.5D, and 3D, enabling users to navigate indoor spaces effectively. Utilizing both WiFi and Bluetooth Low Energy (BLE) technologies, Palmap achieves high-precision positioning, with accuracies of 3-5 meters for WiFi and 1-3 meters for BLE. The company also provides detailed analytics on visitor patterns and behaviors, aiding operators in optimizing management and enhancing service standards through data-driven insights.

Hisign Technology

Series C in 2012
Beijing Hisign Technology Co., Ltd., founded in 1998, specializes in multi-biometrics recognition technology and is recognized as a leading enterprise in China's biometrics industry. The company develops a range of products, including automated biometric identification systems for fingerprint, palm, and face recognition, as well as handwriting and vehicle license plate recognition solutions. Hisign's offerings encompass access control systems, such as intelligent gates and personal information collection workstations, along with mobile terminals for biometric data collection. Their technologies are utilized in various sectors, including public security for criminal investigations, security, and forensics, as well as civil applications in finance, social security, education, and large-scale event management. Hisign is committed to quality, holding multiple ISO certifications, and leverages big data analysis for risk prevention and control in financial contexts.

AISpeech

Series A in 2012
AISpeech is a high-tech startup focused on developing advanced voice interaction technologies that enhance human-machine communication. The company specializes in computer speech recognition, tone analysis, and dialog management techniques. It creates a human-computer dialogue operating system and artificial intelligence chip modules aimed at improving various aspects of voice technology, including speech recognition, speech synthesis, natural language understanding, and voice-print recognition. By providing intelligent natural language interactive services, AISpeech enables clients to access and implement more effective communication solutions.

Global Gem Exchange

Angel Round in 2011
Operator of a diamond exchange intended to facilitate the trading of diamonds and gems in the global market. The company aims to directly connect global diamond suppliers with diamond retailers, enabling clients to increase their gem stock and generate more revenue.

Shenogen Pharma Group

Series A in 2011
Shenogen Pharma Group is a drug discovery and development company.

ChineseAll Digital Publishing

Venture Round in 2010
Chinese Online (中文在线) is a company focused on digital publishing. It provides digital reading products to mobile phones, hand-held terminals, and the internet as well as other media. Chinese Online takes copyright organizations and authors as the genuine digital content source, and collaborates with them to manage the content. It also offers value-added services of digital content such as copyright derivatives and more. As a leading enterprise of digital publishing domestically, Chinese Online has established a complete media publishing model of unique content, variety in media and synchronized publishing.

UNIFLY

Post in 2010
Beijing Unifly Scientific and Technology Company Limited researches, develops, manufactures, and sells filters, low-carbon lubricants, glass cleaners, antifreeze coolants, and other car maintenance products. The company offers car filters, industrial filters, and lube oil products. It serves transportation, automobile parts, mining, metallurgy, power generation, and other industries. Beijing Unifly Scientific and Technology Company Limited was founded in 1995 and is based in Beijing, China with a research and development center in Langfang, China.

UNIFLY

Angel Round in 2007
Beijing Unifly Scientific and Technology Company Limited researches, develops, manufactures, and sells filters, low-carbon lubricants, glass cleaners, antifreeze coolants, and other car maintenance products. The company offers car filters, industrial filters, and lube oil products. It serves transportation, automobile parts, mining, metallurgy, power generation, and other industries. Beijing Unifly Scientific and Technology Company Limited was founded in 1995 and is based in Beijing, China with a research and development center in Langfang, China.

Sumavision

Series D in 2006
Beijing Sumavision Co., Ltd. is a leading Chinese high-tech company specializing in digital television software and systems. It offers comprehensive solutions for video delivery across various platforms, including broadcast, cable, satellite, internet, and mobile services. Sumavision is recognized for its dominance in the domestic market, holding a significant share in front-end hardware products and supplying over 700 local TV stations throughout China. Its solutions are utilized in numerous provinces and national broadcasting systems, showcasing its extensive reach. Sumavision's products are also exported to more than 70 countries, with Europe and North America accounting for a substantial portion of its international trade. The company's commitment to innovation is reflected in its ongoing research and development efforts, encompassing a range of products such as DTV head-end hardware and IPTV/OTT solutions. Established in 2000, Sumavision has achieved considerable growth, culminating in its listing on China's Growth Enterprise Market and a notable market valuation.

ACCB Biotech

Series A in 2005
Beijing ACCB Biotech Ltd. specializes in the development of molecular cancer detection technologies and diagnostic services. Founded in 2004 and based in Beijing, the company focuses on early-stage cancer detection, prognosis evaluation, and personalized cancer therapies. ACCB Biotech offers a range of products, including the EnzymAct kit for non-invasive cancer screening and monitoring of high-risk populations, as well as the BiomarkXP platform for therapeutic efficacy and recurrence monitoring. The company's diagnostics cover various cancers, such as esophageal, gastric, lung, liver, and breast cancer. Additionally, ACCB Biotech provides automated workstation solutions for nucleic acid extraction and other testing services aimed at enhancing individualized treatment plans. The company operates extensive research and production facilities, adhering to strict cleanliness standards, and has established strategic partnerships to bolster its capabilities in the field of precision medicine.

Sumavision

Series A in 2001
Beijing Sumavision Co., Ltd. is a leading Chinese high-tech company specializing in digital television software and systems. It offers comprehensive solutions for video delivery across various platforms, including broadcast, cable, satellite, internet, and mobile services. Sumavision is recognized for its dominance in the domestic market, holding a significant share in front-end hardware products and supplying over 700 local TV stations throughout China. Its solutions are utilized in numerous provinces and national broadcasting systems, showcasing its extensive reach. Sumavision's products are also exported to more than 70 countries, with Europe and North America accounting for a substantial portion of its international trade. The company's commitment to innovation is reflected in its ongoing research and development efforts, encompassing a range of products such as DTV head-end hardware and IPTV/OTT solutions. Established in 2000, Sumavision has achieved considerable growth, culminating in its listing on China's Growth Enterprise Market and a notable market valuation.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.